|
COPS8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.58593146895691E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.22749629641817E-11 |
| Normal-vs-Stage2 |
4.75530000043634E-07 |
| Normal-vs-Stage3 |
2.77480260990615E-11 |
| Normal-vs-Stage4 |
4.87332396659212E-12 |
| Stage1-vs-Stage2 |
8.027800E-01 |
| Stage1-vs-Stage3 |
8.694200E-02 |
| Stage1-vs-Stage4 |
3.237700E-02 |
| Stage2-vs-Stage3 |
3.810200E-01 |
| Stage2-vs-Stage4 |
1.470850E-01 |
| Stage3-vs-Stage4 |
4.816400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38777878078145E-14 |
| Normal-vs-AfricanAmerican |
1.119900E-02 |
| Normal-vs-Asian |
2.01340000005601E-07 |
| Caucasian-vs-AfricanAmerican |
1.817840E-02 |
| Caucasian-vs-Asian |
6.411200E-01 |
| AfricanAmerican-vs-Asian |
1.317620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.71227484915926E-13 |
| Normal-vs-Female |
5.01310104539243E-11 |
| Male-vs-Female |
1.199620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.39449995995022E-09 |
| Normal-vs-Age(41-60Yrs) |
4.17843537547924E-12 |
| Normal-vs-Age(61-80Yrs) |
3.12930015233803E-10 |
| Normal-vs-Age(81-100Yrs) |
2.016500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.044850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.751600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.636000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.087800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.572200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.461400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.136200E-01 |
| Classical-VS-Follicular |
4.135700E-02 |
| Classical-VS-Other |
6.011400E-01 |
| Classical-VS-Normal |
1.66677782686975E-12 |
| Tall-VS-Follicular |
1.724010E-02 |
| Tall-VS-Other |
9.937800E-01 |
| Tall-VS-Normal |
4.77549999544635E-09 |
| Follicular-VS-Other |
3.176000E-01 |
| Follicular-VS-Normal |
7.62610000000219E-05 |
| Other-VS-Normal |
8.173800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.76459999127133E-11 |
| Normal-vs-N1 |
1.4293000116794E-10 |
| N0-vs-N1 |
1.539020E-01 |
|
|
